SECTORAL ASSET MANAGEMENT INC
Q1 2014 13F-HR Holdings
Net value change ($000)
+112,178
(4.8%)
New positions
12
Sold out positions
7
Turnover %
9.0%
Sector allocation + QoQ delta (equities-only)
Snapshot: Change Analysis
Compared to Q4 2013
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| TEVA | 51,600 | 209.8% |
| *AEGERION PHARMACEUTICALS INC | 43,137 | NEW |
| TMO | 36,926 | 64.2% |
| AMGN | 29,259 | 20.3% |
| FOREST LAB | 24,922 | NEW |
| INTERCEPT PHARMACEUTICALS, INC. | 24,567 | NEW |
| KERYX BIOPHARMACEUTICALS | 24,553 | 68.7% |
| PTCT | 23,802 | 2438.7% |
| ALXN | 17,417 | 26.4% |
| Bausch Health | 16,980 | NEW |
Top Reduces (Value $000, Stocks/ETFs)
| PRGO | -50,223 | -100.0% |
| CELG | -40,318 | -33.8% |
| CLDX | -29,037 | -53.8% |
| MEDIVATION | -24,811 | -100.0% |
| PHARMACYCLICS INC | -17,816 | -100.0% |
| MRK | -16,893 | -30.8% |
| THERAVANCE INC | -13,071 | -18.6% |
| NPS PHARMACEUTICALS INC | -11,724 | -21.8% |
| BSX | -11,481 | -45.4% |
| ISRG | -11,050 | -43.8% |
Instrument mix + QoQ Δ (ex-options)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|